• Latest Posts

UPDATE: AC Immune rakes in €52.5M IPO for assault on Alzheimers

World first Drug to ‘dissolve’ Tau-tangles in Alzheimer’s has Phase III Results

French Biotech that makes Drugs faster and cheaper IPO’s for €31M

Alzheimer’s closer to a Vaccine with new Slovakian Phase II Trial

Biotech of the Week: Pharnext, developing next level drugs against Alzheimer’s and Parkinson’s disease

Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia

ADVERTISEMENT

Leading German Biotech recruits New talent for Fight against Alzheimer’s

Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease

Epigenetics Baby of Proteros is Signing Up with Top US Neurology Specialists

Latest Small Molecule against Alzheimer’s Disease Success in Phase I Trials

Hydra’s Immortality is not Myth: Polyps Genetically Reprogram Skin Cells into Neurons

2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

ADVERTISEMENT